Society guideline links: Diagnosis and treatment of premenstrual dysphoric disorder

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Depressive disorders".)

International

●International Society for Premenstrual Disorders (ISPMD): Fourth consensus on auditable standards for diagnosis and management of premenstrual disorder (2016)

●Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies (2009)

●Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities – The role of SSRIs (2006)

United States

●American College of Obstetricians and Gynecologists (ACOG): Practice bulletin on the noncontraceptive uses of hormonal contraceptives (2010)

Europe

●European Medicines Agency (EMA): Guideline on the treatment of premenstrual dysphoric disorder (PMDD) (2011)

United Kingdom

●National Association for Premenstrual Syndrome (NAPS): Guidelines on premenstrual syndrome

●Royal College of Obstetricians and Gynaecologists (RCOG): Green-top guideline for the management of premenstrual syndrome, 2nd edition (2017)